Surgery Partners (SGRY) Projected to Post Quarterly Earnings on Monday

Surgery Partners (NASDAQ:SGRY - Get Free Report) is anticipated to post its Q1 2025 quarterly earnings results before the market opens on Monday, May 12th. Analysts expect Surgery Partners to post earnings of $0.08 per share and revenue of $777.77 million for the quarter. Surgery Partners has set its FY 2025 guidance at EPS.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its quarterly earnings results on Monday, March 3rd. The company reported $0.39 earnings per share for the quarter, topping analysts' consensus estimates of $0.38 by $0.01. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The firm had revenue of $864.40 million during the quarter, compared to the consensus estimate of $828.09 million. On average, analysts expect Surgery Partners to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Surgery Partners Trading Up 0.7 %

Shares of Surgery Partners stock traded up $0.15 on Wednesday, hitting $23.16. 1,116,176 shares of the company's stock traded hands, compared to its average volume of 1,095,773. The company has a fifty day moving average of $22.69 and a two-hundred day moving average of $23.61. Surgery Partners has a one year low of $19.50 and a one year high of $33.97. The company has a market capitalization of $2.97 billion, a price-to-earnings ratio of -48.25, a price-to-earnings-growth ratio of 19.21 and a beta of 1.96. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66.

Insider Transactions at Surgery Partners

In other news, insider Harrison R. Bane sold 56,315 shares of Surgery Partners stock in a transaction on Friday, February 7th. The stock was sold at an average price of $25.64, for a total transaction of $1,443,916.60. Following the sale, the insider now directly owns 107,037 shares in the company, valued at $2,744,428.68. The trade was a 34.47 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Marissa Brittenham sold 3,156 shares of the stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $24.09, for a total transaction of $76,028.04. Following the transaction, the insider now owns 63,408 shares of the company's stock, valued at approximately $1,527,498.72. The trade was a 4.74 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 106,365 shares of company stock valued at $2,711,255 over the last ninety days. 2.30% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on SGRY shares. Benchmark reiterated a "buy" rating and issued a $35.00 price objective on shares of Surgery Partners in a research note on Monday, April 21st. Macquarie dropped their price objective on shares of Surgery Partners from $34.00 to $33.00 and set an "outperform" rating on the stock in a report on Tuesday, March 11th. Finally, Royal Bank of Canada reissued an "outperform" rating and set a $35.00 price objective on shares of Surgery Partners in a research report on Tuesday, March 25th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat, Surgery Partners presently has an average rating of "Moderate Buy" and a consensus price target of $34.75.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.